Bob Ingratta LifeSciences BC Konrad Sechley Gowlings Peter ...

More documents

Recommendations

Info

Why Patent? Competitive Advantage Blocking patents Royalty Stream Attract Investment Negotiation – cross license 10
Cons Expense - National protection - Publication – after 18 months - US may request non-publication* Definite term – typically 20 years from filing date Patent does not provide right to practice - freedom to operate - regulatory approval *conditions apply 11
Page 1 and 2: Bob Ingratta LifeSciences BC Konrad
Page 3 and 4: Managing Intellectual Property Pate
Page 5 and 6: Overview Introduction Bioenergy IP
Page 7 and 8: What is Intellectual Property? Asso
Page 9: Purpose of the patent system Applic
Page 13 and 14: Alternatives to Patenting Trade sec
Page 17 and 18: Eco-Patent Commons “…unleashing
Page 19: Common elements to open access sche
Page 24 and 25: Nature Biotech 24: 643-651 June 200
Page 26 and 27: Increase in US allowance rate - wil
Page 28 and 29: Statutory Subject-Matter CA EP US
Page 30 and 31: New in view of any public disclosur
Page 32 and 33: Public Disclosure (Prior Art) Made
Page 34 and 35: You have an invention - now what? C
Page 36 and 37: Who is an inventor? Person who “c
Page 38 and 39: Determining inventorship is importa
Page 40 and 41: Where and when to file? What to fil
Page 42 and 43: Provisional, informal filing - prob
Page 44 and 45: Patent Cooperation Treaty PCT appli
Page 46 and 47: Patent Cooperation Treaty Chapter I
Page 48 and 49: Considerations Market size Cost Man
Page 50 and 51: Top tips for reducing costs 1. Dete

Bob Ingratta LifeSciences BC Konrad Sechley Gowlings Peter ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?